close 73% van de retail rekeningen verliezen gelden met de handel in CFD`s bij deze aanbieder. Investeringen zijn risicovol en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 73% van de retail beleggers lijdt verlies bij het handelen in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

Home・Aandelen Lijst・Palvella Therapeutics Inc
Search

Palvella Therapeutics Inc

Gesloten

SectorGezondheidszorg

99.6 -3.87

Strong Buy

Prijsupdate 16 jan 2026, 20:59 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

98.79

Max

101.18

Belangrijke statistieken

By Trading Economics

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+82.13% upside

Dividenden

By Dow Jones

Volgende Winsten

30 mrt 2026

Nieuwssentiment

By Acuity

50%

50%

158 / 361 Rangschikking in Healthcare

Palvella Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

16 jan 2026, 23:29 UTC

Populaire aandelen

Stocks to Watch: Atossa Therapeutics, Union Pacific

DJ

Lezen

17 jan 2026, 15:06 UTC

Acquisities, Fusies, Overnames

Trump Purchased Netflix, Warner Bonds in Days After Deal Announcement -- Update

DJ

Lezen

17 jan 2026, 10:30 UTC

Winsten

Supersize CEO Pay Packages Aren't Paying Off for Shareholders -- WSJ

DJ

Lezen

17 jan 2026, 03:10 UTC

Acquisities, Fusies, Overnames

Trump Purchased Netflix, Warner Bonds In Days After Deal Announcement -- WSJ

DJ

Lezen

16 jan 2026, 22:48 UTC

Acquisities, Fusies, Overnames

Rail Regulator Sends $71.5 Billion Union Pacific-Norfolk Southern Deal Back for Redo -- 2nd Update

DJ

Lezen

16 jan 2026, 22:43 UTC

Acquisities, Fusies, Overnames

Union Pacific: Additional Information Requested to Be Provided to Surface Transportation Board

DJ

Lezen

16 jan 2026, 22:22 UTC

Acquisities, Fusies, Overnames

Rail Regulator Sends $71.5 Billion Union Pacific-Norfolk Southern Deal Back for Redo -- Update

DJ

Lezen

16 jan 2026, 21:50 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Tech, Media & Telecom Roundup: Market Talk

DJ

Lezen

16 jan 2026, 21:50 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Auto & Transport Roundup: Market Talk

DJ

Lezen

16 jan 2026, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

DJ

Lezen

16 jan 2026, 21:50 UTC

Marktinformatie

Health Care Roundup: Market Talk

DJ

Lezen

16 jan 2026, 21:48 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Union Pacific, Norfolk Southern Market Share Ruled as Faulty -- Market Talk

DJ

Lezen

16 jan 2026, 21:41 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Union Pacific, Norfolk Southern Deal Rejection Leaves Questions -- Market Talk

DJ

Lezen

16 jan 2026, 21:38 UTC

Acquisities, Fusies, Overnames

Rail Regulator Sends $71.5 Billion Union Pacific-Norfolk Southern Deal Back for Redo -- WSJ

DJ

Lezen

16 jan 2026, 21:30 UTC

Acquisities, Fusies, Overnames

STB: Union Pacific, Norfolk Southern Application Doesn't Include 'Projected Market Shares' as Required

DJ

Lezen

16 jan 2026, 21:30 UTC

Acquisities, Fusies, Overnames

STB: Union Pacific, Norfolk Southern Application Doesn't Include Certain Schedules, Documents Expressly Made Part of Merger Agreement

DJ

Lezen

16 jan 2026, 21:30 UTC

Acquisities, Fusies, Overnames

STB: Union Pacific, Norfolk Southern Application Doesn't Contain Certain Information Required by Regulations

DJ

Lezen

16 jan 2026, 21:30 UTC

Acquisities, Fusies, Overnames

STB: Application Rejected Without Prejudice to Union Pacific, Norfolk Southern Refiling Revised Application Remedying Deficiencies

DJ

Lezen

16 jan 2026, 21:30 UTC

Acquisities, Fusies, Overnames

Surface Transportation Board: Union Pacific, Norfolk Southern Major Merger Application Filed Dec. 19 Incomplete

DJ

Lezen

16 jan 2026, 20:44 UTC

Winsten

5 Takeaways From This Season's Wealth Management Earnings -- Barrons.com

DJ

Lezen

16 jan 2026, 20:42 UTC

Marktinformatie

Oil Futures Post Fourth Straight Weekly Gain -- Market Talk

DJ

Lezen

16 jan 2026, 20:28 UTC

Marktinformatie

U.S. Natural Gas Slips Ahead of Long Weekend -- Market Talk

DJ

Lezen

16 jan 2026, 19:12 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Netflix Could Comment on Structure of Warner Bid During 4Q Results -- Market Talk

DJ

Lezen

16 jan 2026, 18:53 UTC

Marktinformatie

Global Crude Supply Enough to Absorb Any Iran Disruption -- Market Talk

DJ

Lezen

16 jan 2026, 18:41 UTC

Marktinformatie

Netflix's Ad Business Seen as Primary Revenue Driver in 2026 -- Market Talk

DJ

Lezen

16 jan 2026, 18:31 UTC

Marktinformatie

U.S. Oil Rig Count Rises By 1 to 410 -- Market Talk

DJ

Lezen

16 jan 2026, 17:20 UTC

Marktinformatie

Financial Services Roundup: Market Talk

DJ

Lezen

16 jan 2026, 17:20 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

DJ

Lezen

16 jan 2026, 17:20 UTC

Marktinformatie

Health Care Roundup: Market Talk

DJ

Lezen

16 jan 2026, 17:03 UTC

Marktinformatie

Global Equities Roundup: Market Talk

DJ

Lezen

Peer Vergelijking

Prijswijziging

Palvella Therapeutics Inc Prognose

Koersdoel

By TipRanks

82.13% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 181.64 USD  82.13%

Hoogste 212 USD

Laagste 133 USD

Gebaseerd op 15 Wall Street-analisten die 12-maands prijsdoelen bieden voor Palvella Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

15 ratings

15

Buy

0

Hold

0

Sell

Gebaseerd op 15 analisten die aandelenratings hebben gegeven aan Palvella Therapeutics Inc - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

158 / 361 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

$

Andere aandelen uit de sector

MDT

Medtronic PLC

96.83

↓-2.02%

A

Agilent Technologies Inc

139.62

↓-3.71%

VEEV

Veeva Systems Inc

222.3

↑ +1.47%

HQY

HealthEquity Inc

85.02

↓-2.1%

NEOG

Neogen Corp

9.24

↓-2.22%
help-icon Live chat